WST Operating Cash Flow (Statement)

West Pharmaceutical Services · Operating Cash Flow (Statement)

WST logo

WST Operating Cash Flow (Statement)

Latest reported$662.20M
WST TTM Cash from Operations ($36.00M → $662.20M)
High-resolution chart · PNG

WST operating cash flow (statement) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

West Pharmaceutical Services Operating Cash Flow (Statement) — Trailing twelve months (TTM) (USD)
Period endingOperating Cash Flow (Statement) (USD)
662,200,000
715,300,000
754,800,000
693,800,000
676,700,000
664,600,000
653,400,000
702,400,000
752,400,000
756,600,000
776,500,000
768,200,000
707,000,000
710,900,000
724,000,000
654,000,000
675,200,000
646,500,000
584,000,000
571,900,000
500,400,000
504,100,000
472,500,000
430,200,000
419,700,000
376,700,000
367,200,000
334,000,000
314,300,000
291,200,000
288,600,000
296,900,000
284,300,000
287,600,000
263,300,000
253,600,000
246,200,000
237,100,000
219,400,000
215,600,000
216,000,000
217,300,000
212,400,000
190,400,000
185,500,000
172,200,000
182,900,000
205,700,000
195,100,000
210,400,000
220,500,000
221,500,000
219,800,000
192,500,000
187,400,000
159,400,000
147,500,000
135,000,000
130,700,000
136,100,000
144,400,000
136,300,000
138,300,000
143,700,000
134,700,000
152,500,000
137,700,000
129,100,000
132,200,000
138,600,000
135,000,000
150,300,000
132,400,000
119,000,000
129,200,000
111,500,000
129,500,000
138,200,000
143,800,000
126,100,000
111,600,000
92,800,000
85,600,000
85,800,000
76,100,000
62,500,000
68,900,000
63,700,000
70,300,000
63,200,000
69,200,000
60,500,000
58,800,000
61,000,000
53,900,000
55,700,000
38,200,000
39,500,000
32,700,000
33,200,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.